1
Boon, Eline, van der Graaf, Winette T A, Gelderblom, Hans, Tesselaar, Margot E T, van Es, Robert J J, Oosting, Sjoukje F, de Bree, Remco, van Meerten, Esther, Hoeben, Ann, Smeele, Ludi E, Willems, Stefan M, Witjes, Max J H, Buter, Jan, Baatenburg de Jong, Robert J, Flucke, Uta E, Peer, Petronella G M, Bovée, Judith V M G, Van Herpen, Carla M L
Veröffentlicht in: Boon , E , van der Graaf , W T A , Gelderblom , H , Tesselaar , M E T , van Es , R J J , Oosting , S F , de Bree , R , van Meerten , E , Hoeben , A , Smeele , L E , Willems , S M , Witjes , M J H , Buter , J , Baatenburg de Jong , R J , Flucke , U E , Peer , P G M , Bovée , J V M G & Van Herpen , C M L 2017 , ' Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults ' , Head and Neck: Journal of the Sciences and Specialties of the Head and Neck , vol. 39 , no. 1 , pp. 140-146 . https://doi.org/10.1002/hed.24556;
2017
Veröffentlicht in: Boon , E , van der Graaf , W T A , Gelderblom , H , Tesselaar , M E T , van Es , R J J , Oosting , S F , de Bree , R , van Meerten , E , Hoeben , A , Smeele , L E , Willems , S M , Witjes , M J H , Buter , J , Baatenburg de Jong , R J , Flucke , U E , Peer , P G M , Bovée , J V M G & Van Herpen , C M L 2017 , ' Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults ' , Head and Neck: Journal of the Sciences and Specialties of the Head and Neck , vol. 39 , no. 1 , pp. 140-146 . https://doi.org/10.1002/hed.24556;
2017
2
Verhaart, Saskia Lisa, Abu-Ghanem, Yasmin, Mulder, Sasja F, Oosting, Sjoukje, Van Der Veldt, Astrid, Osanto, Susanne, Aarts, Maureen J B, Houtsma, Danny, Peters, Frank P J, Groenewegen, Gerard, Van Herpen, Carla M L, Pronk, Loes M, Tascilar, Metin, Hamberg, Paul, Los, Maartje, Vreugdenhil, Gerard, Polee, Marco, Ten Tije, Albert J, Haanen, John B A G, Bex, Axel, van den Eertwegh, Alfonsus J
Veröffentlicht in: Verhaart , S L , Abu-Ghanem , Y , Mulder , S F , Oosting , S , Van Der Veldt , A , Osanto , S , Aarts , M J B , Houtsma , D , Peters , F P J , Groenewegen , G , Van Herpen , C M L , Pronk , L M , Tascilar , M , Hamberg , P , Los , M , Vreugdenhil , G , Polee , M , Ten Tije , A J , Haanen , J B A G , Bex , A & van den Eertwegh , A J 2021 , ' Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands : An Analysis of Toxicity, Efficacy, and Predictive Markers ' , Clinical genitourinary cancer , vol. 19 , no. 3 , pp. 274.e1-274.e16 . https://doi.org/10.1016/j.clgc.2020.10.003;
2021
Veröffentlicht in: Verhaart , S L , Abu-Ghanem , Y , Mulder , S F , Oosting , S , Van Der Veldt , A , Osanto , S , Aarts , M J B , Houtsma , D , Peters , F P J , Groenewegen , G , Van Herpen , C M L , Pronk , L M , Tascilar , M , Hamberg , P , Los , M , Vreugdenhil , G , Polee , M , Ten Tije , A J , Haanen , J B A G , Bex , A & van den Eertwegh , A J 2021 , ' Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands : An Analysis of Toxicity, Efficacy, and Predictive Markers ' , Clinical genitourinary cancer , vol. 19 , no. 3 , pp. 274.e1-274.e16 . https://doi.org/10.1016/j.clgc.2020.10.003;
2021